ZETAGEN THERAPEUTICS, INC. — Form D
ZETAGEN THERAPEUTICS, INC. of SYRACUSE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-06. The offering totals $15.0M, of which $9.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-02-06
- Form: D
- Accession: 0001730728-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $9.6M
- Remaining: $5.4M
- Investors: 44
- Date of first sale: 2022-04-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-472735
Issuer
- Name: ZETAGEN THERAPEUTICS, INC.
- CIK: 0001730728
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 841 EAST FAYETTE STREET, SYRACUSE, NY, 13210
- Phone: 315-475-2200
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Joe C Loy | Director | Weatherford, TX |
| Joe C Loy | Executive Officer | Weatherford, TX |
| Richard C Warburg | Director | Bethesda, MD |
| Ashok C Kaveeshwar | Director | Bethesda, MD |
| Nikhil Thakur, MD | Director | Andover, MA |
| Nikhil Thakur, MD | Executive Officer | Andover, MA |
| Donald C Brown | Director | Hopkinton, MA |
| David B Tischler | Director | San Francisco, CA |
| David B Tischler | Executive Officer | San Francisco, CA |
| Peter B Finn | Director | Boston, MA |
| Peter B Finn | Executive Officer | Boston, MA |
Other filings by this issuer (5)
More